Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether

Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether Uses, Dosage, Side Effects, Food Interaction and all others data.

Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).

Trade Name Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether
Generic Dihematoporphyrin ether
Dihematoporphyrin ether Other Names bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether, DHP ether, Dihematoporphyrin ether
Type
Formula C68H74N8O11
Weight Average: 1179.385
Monoisotopic: 1178.547705235
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether
Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether

Innovators Monograph

You find simplified version here Bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl Ether

*** Taking medicines without doctor's advice can cause long-term problems.
Share